Beneficial Effects of Dipeptidyl Peptidase-4 Inhibitors on Heart Failure With Preserved Ejection Fraction and Diabetes.
JACC Asia
; 3(1): 93-104, 2023 Feb.
Article
en En
| MEDLINE
| ID: mdl-36873765
BMI, body mass index; BNP, B-type natriuretic peptide; CV, cardiovascular; DM, diabetes mellitus; DPP-4, dipeptidyl peptidase-4; HF, heart failure; HFmrEF, heart failure with mildly reduced ejection fraction; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; HbA1c, glycosylated hemoglobin; LV, left ventricular; LVEF, left ventricular ejection fraction; SGLT-2, sodium-glucose cotransporter-2; diabetes mellitus; dipeptidyl peptidase-4 inhibitor; heart failure with preserved ejection fraction; long-term outcome
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
JACC Asia
Año:
2023
Tipo del documento:
Article
País de afiliación:
Japón
Pais de publicación:
Estados Unidos